Metrovacesa revenue and financials
€10.42Change from previous close: +0.19%Absolute change: +€0.02
In the fiscal year ended December 2025, Metrovacesa reported revenue of €708.46M (+8.37% year over year). Net income was €56.86M, a net margin of 8.0%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +8.37%
- 2025 vs 2024
- Net income growth
- +257.94%
- 2025 vs 2024
- Net margin
- 8.0%
- 2024: 2.4%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | 217 | 95.0 | 32.2 | 211 | — |
| Depreciation and amortization | 1.2 | -3.3 | 3.2 | 6.6 | — |
| Capital expenditure | -0.2 | — | -1.5 | — | -0.8 |
| Investing cash flow | -14.8 | 39.5 | -28.7 | -8.0 | — |
| Financing cash flow | -195 | -144 | -9.2 | -301 | — |
| Dividends paid | -239 | -105 | -100 | -230 | — |
| Share repurchases | -0.3 | — | — | -21.1 | 0.0 |
| Debt issued | 401 | 403 | 568 | 160 | — |
| Debt repaid | -356 | -443 | -478 | -210 | — |
| Net change in cash | 7.6 | -9.9 | -5.7 | -97.5 | — |
| Free cash flow | 217 | 95.0 | 30.8 | 211 | — |